Tradestie Institutional Equity Comparison Engine

OTLK vs CABA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OTLK Overall Edge

OTLK Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OTLK trades at 2.9x Forward P/E with 4781.8% operating margin (-99.4% YoY revenue) versus CABA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro) against CABA sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OTLK
OTLK 2.9x vs CABA N/M Fwd P/E
Growth & Margin Winner OTLK
Op Margin 4781.8% vs 0.0% ยท YoY -99.4% vs +0.0%
Momentum & Technical Winner OTLK
1Y -73.0% vs -51.9% ยท 52W Pos 10% vs 0%
Options & Structure Winner OTLK
BREAKDOWN (55th %ile IV) vs BREAKDOWN (30th %ile IV)
OTLK NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
1M Return -18.82%
1Y Return -73.04%
Forward P/E 2.9x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0
CABA NASDAQ
Cabaletta Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.12
-12.11% 1D
Market Cap $286.9M
1M Return -20.21%
1Y Return -51.92%
Forward P/E N/M
Unified AI Score
47.0 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 66.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OTLK -73.04% CABA -51.92% Spread: +21.12 pp (CABA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OTLK TTM Op. Margin: 4781.8% CABA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OTLK vs CABA. Trailing 12-month operating profitability (OTLK 4781.8% vs CABA 0.0%) and valuation multiples (OTLK 2.9x vs CABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OTLK (7) vs CABA (2)
Institutional Metric OTLK CABA Criterion Row Winner
Market Capitalization Scale $107.1M $286.9M Larger Scale CABA
Trailing P/E Ratio Valuation 2.9x N/M Lower Multiple OTLK
Forward P/E Ratio Valuation 2.9x N/M Lower Multiple OTLK
Revenue Growth (YoY) Growth -99.4% +0.0% Higher Growth CABA
Operating Margin (TTM) Profitability 4781.8% 0.0% Higher Margin OTLK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -3.6% -89.5% Higher ROE OTLK
52-Week Range Position Momentum 10% ($0โ€“$3) 0% ($1โ€“$4) Stronger Trend OTLK
Beta / 30D Volatility Risk Regime 1.47ฮฒ ยท 79% Vol 1.85ฮฒ ยท 101% Vol Lower Realized Risk OTLK
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 47.0 / 100 (HOLD) Higher Composite OTLK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OTLK vs CABA Buy Guide
OTLK BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 55th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OTLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CABA BREAKDOWN
135d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CABA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OTLK nor CABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.